18.ChengPJ,LiuCM,ChuehHY,LinCM,Soong
YK.First-trimesternuchaltranslucency
measurementandechocardiographyat16to18
weeksofgestationinprenataldetectionfor
trisomy18.PrenatDiagn.2003;23:248–251.
19.DevinePC,MaloneFD.Firsttrimesterscreening
forstructuralfetalabnormalities:nuchal
translucencysonography.SeminPerinatol.
1999;23:382–392.
20.HyettJ.Doesnuchaltranslucencyhavearolein
fetalcardiacscreening?PrenatDiagn.
2004;24:1130–1135.
21.SchwarzlerP,CarvalhoJS,SenatMV,etal.
Screeningforfetalaneuploidiesandfetalcardiac
abnormalitiesbynuchaltranslucencythickness
measurementat10-14weeksofgestationaspart
ofroutineantenatalcareinanunselected
population.BrJObstetGynaecol.
1999;106:1029–1034.
22.SouterVL,NybergDA.Sonographicscreening
forfetalaneuploidy:firsttrimester.JUltrasound
Med.2001;20:775–790.
23.TaipaleP,HiilesmaaV,SalonenR,YlostaloP.
Increasednuchaltranslucencyasamarkerfor
fetalchromosomaldefects.NEnglJMed.
1997;337:1654–1658.
24.GhiT,HuggonIC,ZosmerN,NicolaidesKH.
Incidenceofmajorstructuralcardiacdefects
associatedwithincreasednuchaltranslucency
butnormalkaryotype.UltrasoundObstet
Gynecol.2001;18:610–614.
25.HuggonIC,GhiT,CookAC,etal.Fetalcardiac
abnormalitiesidentifiedpriorto14weeks’
gestation.UltrasoundObstetGynecol.
2002;20:22–29.
26.FoyPM,WhellerJJ,SamuelsP,EvansKD.
Evaluationofthefetalheartat14to18weeks’
gestationinfetuseswithascreeningnuchal
translucencygreaterthanorequaltothe95th
percentile.JUltrasoundMed.2013;32:1713–
1719.
27.HansenM,KurinczukJJ,BowerC,WebbS.The
riskofmajorbirthdefectsafterintracytoplasmic
sperminjectionandinvitrofertilization.NEngl
JMed.2002;346:725–730.
28.HutchinsonD,McBrienA,HowleyL,etal.Firsttrimesterfetalechocardiography:identification
ofcardiacstructuresforscreeningfrom6to13
weeks’gestationalage.JAmSocEchocardiogr.
2017;30:763–772.
29.HartgeDR,WeichertJ,KrappM,etal.Resultsof
earlyfoetalechocardiographyandcumulative
detectionrateofcongenitalheartdisease.
CardiolYoung.2011;21:505–517.
30.IliescuD,TudoracheS,ComanescuA,etal.
Improveddetectionrateofstructural
abnormalitiesinthefirsttrimesterusingan
extendedexaminationprotocol.Ultrasound
ObstetGynecol.2013;42:300–309.
31.AIUMpracticeguidelinefortheperformanceof
fetalechocardiography.JUltrasoundMed.
2011;30:127–136.
32.DeRobertisV,RembouskosG,FanelliT,etal.
Thethree-vesselandtracheaview(3VTV)inthe
firsttrimesterofpregnancy:anadditionaltoolin
screeningforcongenitalheartdefects(CHD)in
anunselectedpopulation.PrenatDiagn.
2017;37:693–698.
33.GardinerH,ChaouiR.Thefetalthree-vesseland
trachealviewrevisited.SeminFetalNeonatal
Med.2013;18:261–268.
34.VinalsF,HerediaF,GiulianoA.Theroleofthe
threevesselsandtracheaview(3VT)inthe
diagnosisofcongenitalheartdefects.Ultrasound
ObstetGynecol.2003;22:358–367.
35.DelBiancoA,RussoS,LacerenzaN,etal.Four
chamberviewplusthree-vesselandtracheaview
foracompleteevaluationofthefetalheart
duringthesecondtrimester.JPerinatMed.
2006;34:309–312.
36.SharlandGK,AllanLD.Normalfetalcardiac